Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis

MAbs
Dong Geon KimDo-Hyun Nam

Abstract

Vascular endothelial growth factor (VEGF) and its receptors are considered the primary cause of tumor-induced angiogenesis. Specifically, VEGFR-2/kinase insert domain receptor (KDR) is part of the major signaling pathway that plays a significant role in tumor angiogenesis, which is associated with the development of various types of tumor and metastasis. In particular, KDR is involved in tumor angiogenesis as well as cancer cell growth and survival. In this study, we evaluated the therapeutic potential of TTAC-0001, a fully human antibody against VEGFR-2/KDR. To assess the efficacy of the antibody and pharmacokinetic (PK) relationship in vivo, we tested the potency of TTAC-0001 in glioblastoma and colorectal cancer xenograft models. Antitumor activity of TTAC-0001 in preclinical models correlated with tumor growth arrest, induction of tumor cell apoptosis, and inhibition of angiogenesis. We also evaluated the combination effect of TTAC-0001 with a chemotherapeutic agent in xenograft models. We were able to determine the relationship between PK and the efficacy of TTAC-0001 through in vivo single-dose PK study. Taken together, our data suggest that targeting VEGFR-2 with TTAC-0001 could be a promising approach for cancer treatment.

References

Jan 1, 1975·Annals of Internal Medicine·J Folkman
Jul 1, 1972·CA: a Cancer Journal for Clinicians·A I Holleb, J Folkman
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·C K GoldmanD T Curiel
Feb 5, 2000·Journal of Neurosurgery·S LalF F Lang
Jun 5, 2003·Journal of Neuro-oncology·Andrea SalmaggiAmerigo Boiardi
Dec 10, 2003·Oncogene·Dale L LudwigPeter Bohlen
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Sep 18, 2004·Cancer Research·William A FreijeStanley F Nelson
Jun 18, 2005·Biochemical and Biophysical Research Communications·Napoleone FerraraWilliam Novotny
Dec 21, 2005·Journal of Cellular and Molecular Medicine·Anne Marie ByrneJ H Harmey
Jan 11, 2007·Clinical Therapeutics·Ted Shih, Celeste Lindley
Mar 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John F Deeken, Wolfgang Löscher
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J VredenburghHenry S Friedman
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Sep 12, 2008·Clinical Pharmacology and Therapeutics·W WangJ P Balthasar
Feb 24, 2009·Current Opinion in Cell Biology·Marja LohelaKari Alitalo
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 6, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Eric T WongSteven Brem
Sep 20, 2011·Cell·Michael PotentePeter Carmeliet
Dec 5, 2013·Nature Reviews. Clinical Oncology·Manish A Shah
Dec 7, 2013·Nature Medicine·Birgit ObermeierRichard M Ransohoff

❮ Previous
Next ❯

Citations

May 18, 2020·Journal of Biomolecular NMR·Soyoung ChaKyoung-Seok Ryu
Oct 11, 2017·Frontiers in Immunology·Rok RazpotnikUros Rajcevic
Aug 30, 2017·Molecular Medicine Reports·Fengliang WangQiang Huang

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
enzyme-linked immunosorbent assay
enzyme linked immunosorbent assay

Software Mentioned

Softmax Pro
WinNonlin ( Pharsight
PASW
ImageJ

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis